蛋白激酶B抗体

蛋白激酶B抗体Quantity size:

0.1ml

Concentration:

1mg/ml   Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

蛋白激酶B抗体The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. 蛋白激酶B抗体In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Mutations in this gene have been associated with the Proteus syndrome. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2011]

Also known as:

蛋白激酶B抗体AKT 1; AKT; AKT1; AKT-1; AKT1_HUMAN; C AKT; cAKT; MGC9965; MGC99656; Oncogene AKT1; PKB; PKB alpha; PKB-ALPHA; PRKBA; Protein Kinase B Alpha; Protein kinase B; Proto-oncogene c-Akt; RAC Alpha; RAC alpha serine/threonine protein kinase; RAC; RAC PK Alpha; Rac protein kinase alpha; RAC Serine/Threonine Protein Kinase; RAC-alpha serine/threonine-protein kinase; RAC-PK-alpha; v akt murine thymoma viral oncogene homolog 1; vAKT Murine Thymoma Viral Oncogene Homolog 1.

Specificity:

●

Mouse Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Rabbit, Sheep, .

●

Immunogen: KLH conjugated synthetic peptide derived from human AKT-1 C-terminus.

●

Predicted Molecular Weight: 56kDa.

蛋白激酶B抗体Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl080Ca01白介素8(IL8)多克隆抗体Polyclonal Antibody to Interleukin 8 (IL8)

kl080Po01白介素8(IL8)多克隆抗体Polyclonal Antibody to Interleukin 8 (IL8)

kl080Bo01白介素8(IL8)多克隆抗体Polyclonal Antibody to Interleukin 8 (IL8)

kl080Cp01白介素8(IL8)多克隆抗体Polyclonal Antibody to Interleukin 8 (IL8)

kl080Eq01白介素8(IL8)多克隆抗体Polyclonal Antibody to Interleukin 8 (IL8)

kl080Ga01白介素8(IL8)多克隆抗体Polyclonal Antibody to Interleukin 8 (IL8)

kl093Hu01白介素8抑制因子(IL8INH)多克隆抗体Polyclonal Antibody to Interleukin 8 Inhibitor (IL8INH)

kl448Hu01胰岛素(INS)多克隆抗体Polyclonal Antibody to Insulin (INS)

kl448Mu01胰岛素(INS)多克隆抗体Polyclonal Antibody to Insulin (INS)

kl448Ra01胰岛素(INS)多克隆抗体Polyclonal Antibody to Insulin (INS)

kl448Rb51胰岛素(INS)多克隆抗体Polyclonal Antibody to Insulin (INS)

kl448Si01胰岛素(INS)多克隆抗体Polyclonal Antibody to Insulin (INS)

kl448Ca01胰岛素(INS)多克隆抗体Polyclonal Antibody to Insulin (INS)

kl448Po01胰岛素(INS)多克隆抗体Polyclonal Antibody to Insulin (INS)